{"id":"https://openalex.org/W7204697494","doi":"https://doi.org/10.1016/s2152-2650(26)01753-2","title":"AML-132: Efficacy and Toxicity of FLAG-IDA-Venetoclax Compared With Other Induction Regimens in Newly Diagnosed and Relapsed AML: A Real-World Single-Center Study","display_name":"AML-132: Efficacy and Toxicity of FLAG-IDA-Venetoclax Compared With Other Induction Regimens in Newly Diagnosed and Relapsed AML: A Real-World Single-Center Study","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204697494","doi":"https://doi.org/10.1016/s2152-2650(26)01753-2"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(26)01753-2","doi":"https://doi.org/10.1016/s2152-2650(26)01753-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)01753-2","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5148710320","display_name":"Rita Ahmad","orcid":"https://orcid.org/0000-0002-8207-047X","observed_orcids":["https://orcid.org/0000-0002-8207-047X"]},"institutions":[{"id":"https://openalex.org/I24571045","display_name":"University of North Dakota","ror":"https://ror.org/04a5szx83","country_code":"US","type":"education","lineage":["https://openalex.org/I24571045"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rita Ahmad","raw_affiliation_strings":["University of North Dakota, Fargo, ND, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Dakota, Fargo, ND, USA","institution_ids":["https://openalex.org/I24571045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148675902","display_name":"Tyler Friesen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24571045","display_name":"University of North Dakota","ror":"https://ror.org/04a5szx83","country_code":"US","type":"education","lineage":["https://openalex.org/I24571045"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tyler Friesen","raw_affiliation_strings":["University of North Dakota, Fargo, ND, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Dakota, Fargo, ND, USA","institution_ids":["https://openalex.org/I24571045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056818015","display_name":"Mackenzie Wild","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24571045","display_name":"University of North Dakota","ror":"https://ror.org/04a5szx83","country_code":"US","type":"education","lineage":["https://openalex.org/I24571045"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mackenzie Wild","raw_affiliation_strings":["University of North Dakota, Fargo, ND, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Dakota, Fargo, ND, USA","institution_ids":["https://openalex.org/I24571045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101707169","display_name":"Alexandra L. Brown","orcid":"https://orcid.org/0000-0002-0372-4675","observed_orcids":["https://orcid.org/0000-0002-0372-4675"]},"institutions":[{"id":"https://openalex.org/I24571045","display_name":"University of North Dakota","ror":"https://ror.org/04a5szx83","country_code":"US","type":"education","lineage":["https://openalex.org/I24571045"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandra L Brown","raw_affiliation_strings":["University of North Dakota Hematology Oncology Fellowship, Fargo, ND, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Dakota Hematology Oncology Fellowship, Fargo, ND, USA","institution_ids":["https://openalex.org/I24571045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092984968","display_name":"ARUN RATHINAM","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24571045","display_name":"University of North Dakota","ror":"https://ror.org/04a5szx83","country_code":"US","type":"education","lineage":["https://openalex.org/I24571045"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arun Rathinam","raw_affiliation_strings":["University of North Dakota Hematology Oncology Fellowship, Fargo, ND, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Dakota Hematology Oncology Fellowship, Fargo, ND, USA","institution_ids":["https://openalex.org/I24571045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093063671","display_name":"Audrey Marjamaa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24571045","display_name":"University of North Dakota","ror":"https://ror.org/04a5szx83","country_code":"US","type":"education","lineage":["https://openalex.org/I24571045"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Audrey Marjamaa","raw_affiliation_strings":["University of North Dakota School of Medicine and Health Sciences, Fargo, ND, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Dakota School of Medicine and Health Sciences, Fargo, ND, USA","institution_ids":["https://openalex.org/I24571045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018238087","display_name":"Abe Eric Sahmoun","orcid":"https://orcid.org/0000-0003-2308-7738","observed_orcids":["https://orcid.org/0000-0003-2308-7738"]},"institutions":[{"id":"https://openalex.org/I24571045","display_name":"University of North Dakota","ror":"https://ror.org/04a5szx83","country_code":"US","type":"education","lineage":["https://openalex.org/I24571045"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abe Sahmoun","raw_affiliation_strings":["University of North Dakota, Fargo, ND, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Dakota, Fargo, ND, USA","institution_ids":["https://openalex.org/I24571045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5135299928","display_name":"Kayla Geyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kayla Geyer","raw_affiliation_strings":["Sanford Medical Education, Fargo, ND, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanford Medical Education, Fargo, ND, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074827009","display_name":"Seth M Maliske","orcid":"https://orcid.org/0000-0003-4774-806X","observed_orcids":["https://orcid.org/0000-0003-4774-806X"]},"institutions":[{"id":"https://openalex.org/I4210130571","display_name":"Sanford Medical Center","ror":"https://ror.org/03byzcq48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1305840828","https://openalex.org/I4210130571"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Seth Maliske","raw_affiliation_strings":["Sanford Roger Maris Cancer Center, Fargo, ND, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanford Roger Maris Cancer Center, Fargo, ND, USA","institution_ids":["https://openalex.org/I4210130571"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":null,"first_page":"S444","last_page":"S445"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9769999980926514},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9459999799728394},{"id":"https://openalex.org/keywords/7-3-induction","display_name":"7+3 induction","score":0.8399999737739563},{"id":"https://openalex.org/keywords/relapsed-aml","display_name":"relapsed AML","score":0.8450000286102295},{"id":"https://openalex.org/keywords/newly-diagnosed-aml","display_name":"newly diagnosed AML","score":0.8600000143051147},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.9110000133514404},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.8640000224113464},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7269999980926514},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.9670000076293945},{"id":"https://openalex.org/keywords/bleeding-complications","display_name":"bleeding complications","score":0.6959999799728394},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.6240000128746033},{"id":"https://openalex.org/keywords/consolidation-therapy","display_name":"consolidation therapy","score":0.953000009059906},{"id":"https://openalex.org/keywords/adverse-risk-aml","display_name":"adverse-risk AML","score":0.5059999823570251},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.5740000009536743},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.41600000858306885}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9814000129699707},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.7301999926567078},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6590999960899353},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5216000080108643},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.31279999017715454},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2476000040769577},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.24199999868869781},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.21580000221729279},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.20800000429153442},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.2076999992132187}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(26)01753-2","doi":"https://doi.org/10.1016/s2152-2650(26)01753-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)01753-2","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389219020","https://openalex.org/W7166683958","https://openalex.org/W4405042995","https://openalex.org/W4413776207","https://openalex.org/W4280640050","https://openalex.org/W4417015717","https://openalex.org/W4405051293","https://openalex.org/W3196857658","https://openalex.org/W7141434249","https://openalex.org/W3197222402"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2026-08-31T00:00:00"}